ACAT inhibitors: the search for a novel and effective treatment of hypercholesterolemia and atherosclerosis.
Sliskovic
Drago R
DR
Pfizer Global Research and Development, Ann Arbor Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48105, USA.
Picard
Joseph A
JA
Krause
Brian R
BR
D000818:Animals; D000924:Anticholesteremic Agents / Q000737:chemistry / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000188:drug therapy*; D004195:Disease Models, Animal; D004791:Enzyme Inhibitors / Q000737:chemistry / Q000627:therapeutic use*; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D051379:Mice; D002785:Sterol O-Acyltransferase / Q000037:antagonists & inhibitors* / Q000502:physiology; D013329:Structure-Activity Relationship
D000924:Anticholesteremic Agents; D004791:Enzyme Inhibitors; D002785:Sterol O-Acyltransferase